Thank you.
I had some prior discussions about the bill with some of you. Three different issues have been raised: compulsory reporting, consideration for payment and body parts other than organs. Let me say a bit about each of those issues.
Compulsory reporting is an issue where there was a constitutional question raised, because the bill now says “reporting to a designated authority”. I looked at the definition of “Attorney General” in the Criminal Code because the bill says there has to be consent by the Attorney General. The term “Attorney General” in the Criminal Code is defined to mean the Attorney General or Solicitor General for the province in which proceedings are taken, and the Attorney General of Canada pertains only to Yukon, Nunavut and the Northwest Territories.
That issue of constitutionality, as I see it, can be answered in one of four ways. One is just to leave the bill as it is and to leave the issue of who the designated authority is to the Governor in Council, who could in theory, in consultation with the provinces, designate provincial authorities for each province where the Attorney General or the Solicitor General has the power to consent to prosecution. That would be one option.
A second option would be to change the bill to require the consent of the Attorney General of Canada, as opposed to just the Attorney General, so as to allow for the designated authority to be federal.
A third option would be to change the consent requirement as it exists in some parts of the Criminal Code to be either the Attorney General of Canada or the Attorney General or Solicitor General of the province, which would maximize flexibility in the designation of the relevant authority.
A fourth option is to change the bill so that instead of requiring “reporting by an authority designated by the Governor in Council”, it would require “reporting to the Attorney General”. That would mean the Attorney General as defined in the Criminal Code, which would mean reporting to the Attorney General or Solicitor General in each province where proceedings might be taken. I point out that this is a common form of reporting. There's a lot of reporting legislation right now in Canada for child abuse, for gunshot wounds, and a lot of this reporting goes straight to the prosecutorial authorities.
Those are the options that I saw for the first issue about reporting.
In terms of consideration, the issue that has arisen is whether the bill as it now stands would penalize compensation to the donor for expenses incurred or income lost. There are a couple of ways to deal with that. One is just to leave it to prosecutorial discretion and the consent of the Attorney General and not change the bill.
A second is to have specific wording, and instead of saying “consideration”, say “consideration for the purpose of exploitation”, which is the language used right now in the Declaration of Istanbul on Organ Trafficking and Transplant Tourism. Exploitation is a well-known concept in the Criminal Code, where it's mentioned 36 times. In particular, it's part of the offence of trafficking of persons in the Criminal Code.
The third issue I heard raised was the issue of body parts—whether the reference to organs is too narrow, and whether the bill should also refer to “tissue”. If the bill were amended to refer to tissue, the question would arise whether that's too broad, and whether some forms of tissue would need to be exempted.
Again, there's more than one answer. One is to do nothing, because the fact that something more can be done that is worthwhile is another argument for doing something, which is in itself worthwhile, and which is in the bill right now. A second answer is to add “tissue”, but to rely on the concept of exploitation to avoid overbreadth. Presumably, consideration for those tissues, which the bill would not intend to capture, would not be consideration for the purpose of exploitation. The third answer is to add “tissue” but exempt specific tissue listed by regulation. I would think there would have to be medical consultation to determine which tissue would fall within the regulation.
Those are the various issues I heard discussed, and the various options I present for your consideration. I realize there's a strategic consideration involved because if there's an amendment then it has to go back to the Senate and in theory any one senator could delay the passage of the bill through the Senate with amendment.
I feel in terms of strategic considerations you're in a better place to deal with them then I am. I leave that to your wisdom.